Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
17.62%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth17.62%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-189.76%
20%
—
—
Never
—
5 Years
Score—
Net Growth-189.76%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Lantern Pharma Inc fundamental performance
Across Lantern Pharma Inc's full reported history, from 2020 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 5M to -$ 17M. Revenue increased in 0% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.66 | — |
1 Year2025-08-12 | $ 4.45 | -40.22% |
5 Years2021-08-12 | $ 12.87 | -79.33% |
All Time2020-06-11 | $ 14.95 | -82.21% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-06-11 |
|---|---|---|---|---|
| Price | $ 2.66 | $ 4.45 | $ 12.87 | $ 14.95 |
| Return | — | -40.22% | -79.33% | -82.21% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 17M | $ 10.11B |
| 2024 | $ 0.00 | -$ 20M | $ 24M |
| 2023 | $ 0.00 | -$ 15M | $ 41M |
| 2022 | $ 0.00 | -$ 14M | $ 55M |
| 2021 | $ 0.00 | -$ 12M | $ 70M |
| IPO2020 | $ 0.00 | -$ 5M | $ 19M |
Explore beyond LTRN
You're looking at Lantern Pharma Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
